← Browse by Condition
Medical Condition

renal cell cancer metastatic

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1

ClinicalMetric aggregates all active clinical trials for renal cell cancer metastatic from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT06451497 Phase 1
Recruiting

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Enrollment
100 pts
Location
United States
Sponsor
Zumutor Biologics Inc.
View Trial →